Tag: CDMO

Fujifilm cell culture manufacturing facility to come up in Holly Springs, NC

pallavi123- March 19, 2021

Fujifilm has selected Holly Springs of North Carolina as the location for its new $2 billion cell culture manufacturing facility in the US. In January ... Read More

EQT offers to acquire Swedish CDMO Recipharm for $2.8bn

pharmanewsdaily- December 15, 2020

Swedish private equity company EQT Partners has offered to takeover Recipharm, a Swedish pharma contract development and manufacturing organization (CDMO), for SEK 23.6 billion ($2.82 ... Read More

Novavax NVX-CoV2373 COVID-19 vaccine candidate to be manufactured by FDB

pharmanewsdaily- July 24, 2020

Novavax has signed an agreement with FUJIFILM Diosynth Biotechnologies (FDB), a US-based contract development and manufacturing organization (CDMO), for the manufacturing of bulk drug substance ... Read More

India-based Piramal Pharma secures $490m investment from Carlyle Group

pharmanewsdaily- June 30, 2020

The Carlyle Group has signed a deal worth around $490 million with Piramal Enterprises, to acquire a stake of 20% from the Indian conglomerate's pharma ... Read More

Piramal Pharma acquires solid oral dosage drug product facility in Sellersville

pharmanewsdaily- June 20, 2020

Piramal Pharma Solutions has agreed to acquire the solid oral dosage drug product manufacturing facility of G&W Laboratories in Sellersville, Pennsylvania for an undisclosed price. ... Read More

Japanese group AGC offers €240m bid for Italian biotech company Molmed

pharmanewsdaily- March 18, 2020

Japanese conglomerate AGC has offered a takeover bid of €240 million to acquire 100% of Italian biotech company cum contract development and manufacturing organization (CDMO) ... Read More

WuXi vaccine manufacturing facility in Ireland gets $3bn contract

pharmanewsdaily- February 18, 2020

Chinese CDMO WuXi Vaccines has signed a 20-year contract worth around $3bn with an undisclosed vaccine company to use a dedicated vaccine manufacturing facility in ... Read More

Catalent Pharma Solutions acquires cell and gene therapy CDMO MaSTherCell

pharmanewsdaily- February 11, 2020

Drug manufacturer Catalent Pharma Solutions has wrapped up its previously announced $315 million acquisition of MaSTherCell Global, a technology-focused cell and gene therapy contract development ... Read More

Recipharm to acquire British CDMO Consort Medical for £505m

pharmanewsdaily- November 20, 2019

Recipharm acquisition of Consort Medical : Swedish pharma group Recipharm has agreed to acquire Consort Medical, a British contract development and manufacturing organization (CDMO) for ... Read More